Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bvf Inc/il
Relationship:   Indirect Beneficial Ow...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   49,829,941    

Indirect Shares

   136,880,248      
Direct Value   $2,550,278,644    

Indirect Value

   $7,642,993,607      
Total Shares   186,710,189      
Total Value   $10,193,272,250      


Neurocrine Biosciences Inc $717,347,494 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $47,538,035 Ligand Pharmaceuticals Inc $1,305,525,897 Curis Inc $3,390,252 Repligen Corp $475,422,697 Gyre Therapeutics $1,054,262 Neurocrine Biosciences Inc $717,347,494 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $47,538,035 Ligand Pharmaceuticals Inc $1,305,525,897 Curis Inc $3,390,252 Repligen Corp $475,422,697 Gyre Therapeutics $1,054,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    19   
    2    

     Stock price went up :
    18   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   18.0   
   -2.0   
     Percentage Gain/Loss :
   64.8%
 -200.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX 10% Owner 2010-04-12 5,041,447 2010-04-12 15,124,341    Premium*  
            NPS Pharmaceuticals Inc NPSP Indirect Beneficial Ow... 2008-03-11 0 2008-09-22 4,383,115    Premium*  
            Astex Pharmaceuticals Inc ASTX Indirect Beneficial Ow... 2008-05-01 0 2008-05-09 5,753,399    Premium*  
            Neurobiological Technologies Inc NTII 10% Owner 2009-10-21 331,998 2009-10-21 995,994    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 2009-12-22 6,830,972 2009-12-22 20,492,916    Premium*  
            Capstone Therapeutics Corp CAPS Indirect Beneficial Ow... 2008-10-10 0 2008-10-14 5,136,888    Premium*  
            Adolor Corp ADLR Indirect Beneficial Ow... 2008-10-10 4,428,032 2008-10-31 6,214,551    Premium*  
            Dynavax Technologies Corp DVAX 10% Owner 2009-09-10 4,278,851 2009-09-10 12,836,553    Premium*  
            Ligand Pharmaceuticals Inc LGND Indirect Beneficial Ow... 2009-07-01 15,169,950 2009-07-01 45,509,850    Premium*  
            Curis Inc CRIS Indirect Beneficial Ow... 2009-02-03 8,921,716 2009-04-27 5,951,716    Premium*  
            Repligen Corp RGEN Indirect Beneficial Ow... 2009-07-07 2,765,050 2009-07-07 8,295,150    Premium*  
            Gyre Therapeutics GYRE Indirect Beneficial Ow... 2009-10-16 2,061,925 2009-10-16 6,185,775    Premium*  
* Premium Members only  

Records found :    195         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
DVAX Dynavax Technologies Corp Direct Beneficial Owner   –       –       •   2009-07-29 4 S $1.85 $210,350 D/D (113,500) 5,906,057 0 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-07-07 4 B $4.24 $490,718 I/I 115,700 5,208,200 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-09 4 B $4.29 $525,966 I/I 122,700 5,606,550 1.5 -
NPSP NPS Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-03-10 4 B $3.73 $469,350 I/I 126,000 4,608,215 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-05-15 4 B $4.63 $584,453 I/I 126,300 5,001,400 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-12-01 4 B $1.86 $245,476 I/I 131,700 13,191,953 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-23 4 B $3.22 $426,099 I/I 132,300 4,710,132 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-11 4 B $0.60 $83,224 I/I 139,100 8,282,199 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-03-11 4 B $4.90 $694,267 I/I 141,800 4,639,800 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2009-07-01 4 S $2.97 $423,633 D/D (142,700) 15,169,950 0 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-24 4 B $2.01 $287,573 I/I 143,000 11,116,653 1.5 -
NPSP NPS Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-03-07 4 B $3.81 $556,057 I/I 146,100 4,482,215 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-03-18 4 B $4.96 $759,110 I/I 153,000 4,831,500 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-23 4 B $4.47 $690,969 I/I 154,600 6,217,477 1.5 -
AMAG AMAG Pharmaceuticals Inc officerTitle   –       –       •   2006-01-12 4 S $15.69 $2,491,704 I/I (158,700) 1,116,433 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-01 4 B $5.00 $825,528 I/I 165,000 6,892,477 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-11 4 B $1.39 $233,429 I/I 167,850 10,252,798 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-05 4 B $0.60 $108,186 I/I 180,400 8,008,199 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-21 4 B $4.95 $920,905 I/I 186,000 8,109,577 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-21 4 B $1.78 $331,751 I/I 186,744 10,973,653 1.5 -
NPSP NPS Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-09-19 4 S $8.55 $1,638,621 I/I (191,600) 4,666,315 0 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-12-02 4 B $1.90 $365,928 I/I 193,000 13,384,953 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-10 4 B $1.36 $270,072 I/I 198,000 10,084,948 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-14 4 B $1.30 $273,050 I/I 210,000 10,571,309 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-04 4 B $5.08 $1,068,085 I/I 210,100 7,102,577 1.5 -
  195  Records found
  1   2   3   4   5   6  7   8      
  Page 6 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us